(DGAP-Media / 10.07.2013 / 14:06) PRESS RELEASE exceet demonstrates its leading role in the field of implants - Development partnership with Swiss medical device company MyoPowers Ebbs/Berlin, July 10, 2013 - In cooperation with the Swiss company MyoPowers Medical Technologies SA and further partners, the two members of exceet Group SE AEMtec GmbH and Contec GmbH are developing an implant for the treatment of incontinence. After the first prototypes have successfully been tested, the phase of industrialisation is due to start after passing the verification stage, followed by a first clinical trial. The know-how of the exceet Group in the development and manufacturing of miniaturised electronic components, modules and systems allows the Swiss producer of medical devices MyoPowers to further develop modern therapies in the field of urology and develop an implant that will significantly improve the quality of life for patients suffering incontinence. Artificial Urinary Sphincter (AUS) of MyoPowers The jointly developed implant 'Artificial Urinary Sphincter' is a modular artificial urethral sphincter for the treatment of incontinence. The feature that sets it apart is that the physician can postoperatively adjust the closure force by means of a special remote control. The patient receives a simple remote control to operate the implant. For further information, please go to www.myopowers.com. Unique features The implant, which can be used to treat female and male patients alike, will be a global innovation in the field of medical implants for urology treatments. A special remote control allows the physician to simply adjust the closing pressure of the implant postoperatively. The product is expected to significantly improve the quality of life for patients concerned. 'Such development projects are proof that our technological know-how in the field of medical devices, particularly concerning implants, is ideally tailored to the market. Once again, AEMtec and Contec have managed to demonstrate their extraordinary and outstanding industry expertise,' says Ulrich Reutner, CEO of exceet Group SE. Contact: exceet Group SE Fabian Rau Vice President Marketing E-mail: [email protected] Tel: +49 (0)172/3653167 Contec GmbH Contec is the European specialist with long-standing experience in the development and automated manufacturing of high-quality and complex electronic modules, components and systems. In the field of medical devices, for example, Contec assumes the overall responsibility for the development and manufacturing of medical devices, including the entire testing strategy and qualification of the test systems, as well as their approval. AEMtec GmbH AEMtec in Berlin offers the development, industrialisation, qualification and production of miniaturised and complex electronic circuits for application in Class III (active implants) devices using high-end chip-level technologies such as COB and Flip Chip. Thanks to the company being part of a strong group and cooperating with renowned research institutions, the clients benefit from distinct solution expertise, state-of-the-art technologies and the flexibility of a medium-sized enterprise. exceet Group exceet Group SE is listed in the Prime Standard of the Frankfurt Stock Exchange. exceet is among the leading providers of embedded electronics and security solutions with production facilities in Switzerland, Austria, the Czech Republic, Germany and the Netherlands. End of Media Release --------------------------------------------------------------------- Issuer: exceet Group SE Key word(s): Research/Technology 10.07.2013 Dissemination of a Press Release, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: exceet Group SE 114, avenue Gaston Diderich L-1420 Luxemburg Grand Duchy of Luxembourg Phone: +352 2600 3181 Fax: +352 2600 3133 E-mail: [email protected] Internet: www.exceet.ch ISIN: LU0472835155, LU0472839819 WKN: A0YF5P, A1BFHT Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in München End of News DGAP-Media --------------------------------------------------------------------- 220629 10.07.2013